Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28235
Title: What does endemic COVID-19 mean for the future of rituximab?
Austin Authors: Liew, David F L ;Robinson, Philip C
Affiliation: University of Queensland School of Clinical Medicine, Faculty of Medicine, Herston, QLD, Australia
Department of Medicine, University of Melbourne, Parkville, VIC, Australia
Rheumatology
Royal Brisbane & Women's Hospital, Metro North Hospital & Health Service, Herston, QLD, Australia
Clinical Pharmacology and Therapeutics
Issue Date: 15-Nov-2021
Date: 2021-11-15
Publication information: The Lancet. Rheumatology 2021; online first: 15 November
URI: https://ahro.austin.org.au/austinjspui/handle/1/28235
DOI: 10.1016/S2665-9913(21)00362-3
Journal: The Lancet. Rheumatology
PubMed URL: 34806035
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

32
checked on Dec 6, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.